Clinical Trial Update: Central Serous Chorioretinopathy and Micropulse Laser Treatment

View source ↗

Summary

The clinical trial NCT06346405 is evaluating micropulse laser treatment for Central Serous Chorioretinopathy and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Central Serous Chorioretinopathy | Status: RECRUITING